David Stock

43 papers receiving 2.1k citations

David Stock's Hit Papers

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial 2023 · 88 citations
880+2+4Years since publication50100150200250

Peers

David Stock
Comparison fields: 5 of 114
  • Psychiatry and Mental health 1.1k
  • Virology 292
  • Pathology and Forensic Medicine 409
  • Infectious Diseases 388
  • Neurology 107
Replace Carolyn Napier with:
Carolyn Napier United Kingdom
Annie Lannuzel France
Paul Dyken United States
P. Donatsch Switzerland
Laura E. Pope United States
Akiko Kikuchi Japan
J.G. Gobert France
Yuyuan Huang China
Francesco Nicoli France
Wenxin Li China
David Stock relative to Carolyn Napier United Kingdom Carolyn Napier's profile →
Citations per field
00.5×10×15×20×23×
Carolyn Napier · 1×
Citations per year

Countries citing papers authored by David Stock

Since Specialization
Citations

This map shows the geographic impact of David Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stock more than expected).

Fields of papers citing papers by David Stock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stock. The network helps show where David Stock may publish in the future.

Co-authors

The 25 scholars most cited alongside David Stock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Stock Line = papers co-authored together David Stock links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Hit paper breakdown →
2019283
2
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Hit paper breakdown →
2019273
3
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2020245
4 2013227
5 2000205
6 2000141
7 2000101
8
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Hit paper breakdown →
202388
9 200679
10 199875
11 202263
12 201552
13 199639
14 202338
15 199938
16 201736
17 201832
18 201626
19 200922
20 200921

About David Stock

David Stock is a scholar working on Psychiatry and Mental health, Infectious Diseases, Virology, Pediatrics, Perinatology and Child Health and Surgery, having authored 49 papers that have together received 2.2k indexed citations. Recurring topics across this work include Migraine and Headache Studies (11 papers), HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers), Total Knee Arthroplasty Outcomes (3 papers), Biosimilars and Bioanalytical Methods (2 papers), Analytical Chemistry and Chromatography (2 papers) and Orthopaedic implants and arthroplasty (2 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Virology (292 citations), Pathology and Forensic Medicine (409 citations), Infectious Diseases (388 citations) and Neurology (107 citations). David Stock has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Peter J. Goadsby, Robert Croop, Vladimir Coric, Richard B. Lipton, Elyse Stock, Charles M. Conway, Micaela Forshaw, George Manos, David W. Dodick and Ronald N. Marcus. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Journal of the International AIDS Society, The Lancet Neurology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact